Literature DB >> 12815503

Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS).

Roxanna Farinpour1, Eric N Miller, Paul Satz, Ola A Selnes, Bruce A Cohen, James T Becker, Richard L Skolasky, Barbara R Visscher.   

Abstract

Despite the use of laboratory markers in estimating HIV prognosis, significant variation in the natural history of HIV-1 infection remains unexplained. Recent studies suggest psychosocial risk factors have important prognostic significance in HIV disease. The objective of the present study was to examine the prognostic influence of age, general intellectual functioning, and emotional distress across the spectrum of HIV disease progression. The study sample was drawn from the Multicenter AIDS Cohort Study (MACS), a 13-year, prospective study of HIV-seropositive men recruited from four study centers across the country. The participants were 1,231 HIV-seropositive MACS participants, followed from baseline (median 8/15/87) to the end of the observation period (12/15/98). HIV disease progression was evaluated with respect to three outcome measures: (1) number of years from baseline testing to the first AIDS defining illness (progression to AIDS), (2) years from baseline to HIV-dementia (progression to dementia), and (3) years from baseline to death (survival). The influence of psychosocial risk factors on outcome measures was evaluated using survival analyses. General intellectual functioning, age, and somatic symptoms of depression, were found to be significant predictors of HIV disease progression and survival. Older age at baseline was associated with a more rapid progression to dementia and death. Lower Shipley IQ estimates were associated with a more rapid disease progression (AIDS and dementia) and shortened survival. Somatic symptoms of depression were associated with shortened survival. In addition, age, IQ, and somatic symptoms of depression, had an additive effect with an increase in the number of risk factors associated with accelerated disease progression and shortened time to death. These findings remained consistent, despite controlling for baseline CD4 and HIV medication use. Psychosocial cofactors are important in understanding HIV disease progression. Methods for estimating HIV prognosis may become more reliable if psychosocial factors are considered. Future research will clarify if psychosocial risk factors reflect central nervous system integrity, brain reserve capacity or mediate morbidity and mortality through social economic status, access to health care and other social correlates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815503     DOI: 10.1076/jcen.25.5.654.14577

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  66 in total

1.  Platelet decline as a predictor of brain injury in HIV infection.

Authors:  Ann B Ragin; Gypsyamber D'Souza; Sandra Reynolds; Eric Miller; Ned Sacktor; Ola A Selnes; Eileen Martin; Barbara R Visscher; James T Becker
Journal:  J Neurovirol       Date:  2011-09-29       Impact factor: 2.643

2.  Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.

Authors:  Bisola O Ojikutu; Hui Zheng; Rochelle P Walensky; Zhigang Lu; Elena Losina; Janet Giddy; Kenneth A Freedberg
Journal:  S Afr Med J       Date:  2008-03

3.  Silent endurance and profound loneliness: socioemotional suffering in African Americans living with HIV in the rural south.

Authors:  Margaret Shandor Miles; Malika Roman Isler; Bahby B Banks; Sohini Sengupta; Giselle Corbie-Smith
Journal:  Qual Health Res       Date:  2010-11-01

4.  Sex differences in HIV-associated cognitive impairment.

Authors:  Erin E Sundermann; Robert K Heaton; Elizabeth Pasipanodya; Raeanne C Moore; Emily W Paolillo; Leah H Rubin; Ronald Ellis; David J Moore
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

Review 5.  Faces of Frailty in Aging with HIV Infection.

Authors:  Marion Thurn; Deborah R Gustafson
Journal:  Curr HIV/AIDS Rep       Date:  2017-02       Impact factor: 5.071

Review 6.  Cognitive reserve in aging.

Authors:  A M Tucker; Y Stern
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

7.  Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.

Authors:  Joseph A Delaney; Robin M Nance; Bridget M Whitney; Frederick L Altice; Xinyuan Dong; Maria Esther Perez Trejo; Mika Matsuzaki; Faye S Taxman; Geetanjali Chander; Irene Kuo; Rob Fredericksen; Lauren N Strand; Joseph J Eron; Elvin Geng; Mari M Kitahata; William C Mathews; Kenneth Mayer; Richard D Moore; Michael S Saag; Sandra Springer; Redonna Chandler; Shoshana Kahana; Heidi M Crane
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

8.  Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria.

Authors:  Olurotimi Adejumo; Bibilola Oladeji; Onoja Akpa; Kay Malee; Olusegun Baiyewu; Adesola Ogunniyi; Scott Evans; Baiba Berzins; Babafemi Taiwo
Journal:  Int J STD AIDS       Date:  2015-09-18       Impact factor: 1.359

9.  Self-perception of aging among HIV-positive and HIV-negative participants in the Multicenter AIDS Cohort Study.

Authors:  Karen Nieves-Lugo; Deanna Ware; M Reuel Friedman; Sabina Haberlen; James Egan; Andre L Brown; Omar Dakwar; Michael Plankey
Journal:  AIDS Care       Date:  2019-09-23

10.  Depression and HIV in Botswana: a population-based study on gender-specific socioeconomic and behavioral correlates.

Authors:  Reshma Gupta; Madhavi Dandu; Laura Packel; George Rutherford; Karen Leiter; Nthabiseng Phaladze; Fiona Percy-de Korte; Vincent Iacopino; Sheri D Weiser
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.